Mounjaro and Trulicity are two injectable medications that treat type 2 diabetes. Learn more about their key similarities, ...

The phase 3 trial success over Lilly’s Trulicity (dulaglutide), an already-marketed GLP-1 class rival, further bolsters semaglutide's profile ahead of its anticipated approval later this year as ...

GPs are free to prescribe semaglutide to all eligible patients in line with NICE guidelines after long-term shortages have been resolved.

Of the 37.1 million patients with type 2 diabetes, 810,390 were new semaglutide users, 326,282 were treated with dulaglutide, 25,936 with exenatide (Byetta, Bydureon), 715,802 with empagliflozin ...

Dulaglutide has been routed to NICE Centre for Guidelines where the topic will be considered for potential inclusion within the next review of NG18: Diabetes (type 1 and type 2) in children and young ...